文献速递外周动脉疾病

使用Jetstream斑块旋切系统治疗复杂股腘动脉病变的新治疗概念

Novel Therapeutic Concepts for Complex Femoropopliteal Lesions Using the Jetstream Atherectomy System.
PubMed 文献 · J Endovasc Ther · 2023-03-24

这项前瞻性单中心观察性研究纳入2017年1月至2019年7月间162例严重钙化股腘动脉病变患者,先使用Jetstream斑块旋切系统行旋切,再行药物涂层球囊血管成形术。12个月随访时卢瑟福分级和踝肱指数均显著改善,免于靶病变血运重建率为92.6%,免于靶血管血运重建率为95.1%。

要点

  • 162例患者共治疗210处未置入支架病变和22处置入支架病变,7.4%患者接受补救性支架置入。
  • 装置成功率为88%,手术成功率为99%,无症状性外周栓塞发生率为6.2%。
  • 12个月随访时免于靶病变血运重建率为92.6%,免于靶血管血运重建率为95.1%。

核心结论

  • 旋转斑块旋切联合药物涂层球囊可安全用于长段、钙化的(非)闭塞性病变,补救性支架置入率相对较低,中期临床结果良好。
  • 作者认为,即使对于此类复杂钙化股腘动脉病变和闭塞,在每日临床实践中也可鼓励血管专科医生选择血管内优先策略。

研究设计与样本

  • 前瞻性单中心观察性研究,纳入2017年1月至2019年7月间严重钙化股腘动脉病变伴慢性肢体缺血卢瑟福1-5级患者。
  • 患者接受Jetstream斑块旋切系统旋切后行药物涂层球囊血管成形术,病变钙化按外周动脉钙化评分系统(PACSS)分类,病变复杂性按跨大西洋学会间共识(TASC)分类。
  • 共162例连续患者,治疗210处未置入支架病变和22处置入支架病变,随访至12个月。

主要发现

  • 12例(7.4%)患者接受补救性支架置入;平均病变长度24.2±4.8 cm;51%为慢性完全闭塞(平均闭塞长度18.2±5.1 cm)。
  • TASC C病变38例(23.5%),TASC D病变124例(76.5%);平均PACCS评分3.3±0.9;装置成功率88%,手术成功率99%。
  • 栓塞保护装置使用率11.7%;穿孔或夹层发生率为0;无症状性外周栓塞10例(6.2%)。
  • 12个月随访时,基线平均卢瑟福分级3.7±0.6显著降至1.0±0.9(p<0.05),基线平均踝肱指数0.4±0.1显著升至0.8±0.2(p<0.05)。
  • 12个月随访时,92.6%免于靶病变血运重建,95.1%免于靶血管血运重建,双功能超声测得二元再狭窄22例(13.6%)。

临床怎么用

  • 作者认为,本研究可鼓励血管专科医生在每日临床实践中对此类复杂钙化股腘动脉病变和闭塞选择血管内优先策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The presence of severe arterial calcification is associated with less favorable outcomes in terms of procedural and clinical success as well as higher rates of major adverse limb events. Recent studies incorporating rotational atherectomy for effective preparation of severely calcified lesions demonstrate beneficial procedural outcomes by obtaining maximal luminal gain and improved long-term outcomes. METHODS: This prospective single-center, observational study includes patients with severely calcified femoropopliteal lesions with chronic limb ischemia Rutherford 1-5 between January 2017 and July 2019, who underwent atherectomy using the Jetstream Atherectomy system, followed by drug-coated balloon angioplasty. Lesion calcification was categorized by the Peripheral Arterial Calcium Scoring System (PACSS), whereas lesion complexity was classified by the Transatlantic Inter-Society Consensus (TASC). Safety and efficacy aspects in terms of vessel injury, thromboembolism, and clinical success were systematically analyzed up to 12 months of follow-up (FU). RESULTS: In 162 consecutive patients, 210 non-stented and 22 stented lesions were treated. Twelve (7.4%) patients received bail-out stenting. Mean lesion length was 24.2±4.8 cm; 51% were chronic total occlusions (mean occlusion length 18.2±5.1 cm). TASC C lesions were present in 38 patients (23.5%) and TASC D lesions in 124 patients (76.5%). The mean PACCS score was 3.3±0.9. Device success was achieved in 88%; procedural success was noted in 99% of the lesions. Embolic protection device was used in 11.7%. Perforation or dissection occurred in none of the cases. Asymptomatic peripheral embolization was noted in 10 patients (6.2%). Clinical FU at 12 months was available in 157 of 162 patients (96.9%). At 12 month FU, (1) mean Rutherford classification at baseline of 3.7±0.6 significantly dropped to 1.0±0.9 (p<0.05), (2) baseline mean anke-brachial index (ABI) of 0.4±0.1 significantly increased to 0.8±0.2 (p<0.05), (3) 92.6% were free from target lesion revascularization (TLR), (4) 95.1% were free from target vessel revascularization (TVR), and (5) binary restenosis measured by duplex occurred in 22 patients (13.6%). Multivariate analyses showed lesion length as predictive of stent placement (p=0.02), whereas both lesion length (p=0.006) and PACCS score (p=0.02) are predictive of clinical success. CONCLUSION: Rotational atherectomy in combination with drug-coated balloon (DCB) can be safely performed in long, calcified (non-) occlusive lesions with a relatively low rate of bail-out stenting and favorable clinical mid-term results. CLINICAL IMPACT: In this prospective, single arm study we demonstrated that combination treatment using rotational atherectomy and DCB is safe and effective in complex and calcified TASC C/D femoropopliteal lesions in patients with claudication or CLTI in a real-world clinical setting. Despite mean lesion length of >20cm and a relatively high rate of chronic total occlusions, the rate of bail-out stenting was surprisingly low (7.4%), whereas the rates of freedom from TLR and TVR were surprisingly high. Thus, our study may encourage vascular specialists to choose an endovascular -first approach even in such complex and calcified femoropopliteal lesions and occlusions in daily clinical practice.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Dukic D, Martin K, Lichtenberg M, et al. Novel Therapeutic Concepts for Complex Femoropopliteal Lesions Using the Jetstream Atherectomy System. J Endovasc Ther. 2023. PMID: 36960883. doi:10.1177/15266028231161246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。